A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety Profile and Pharmacokinetic Parameters of Udenafil 150 mg in Healthy Mexican Subjects.

Trial Profile

A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety Profile and Pharmacokinetic Parameters of Udenafil 150 mg in Healthy Mexican Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Oct 2013

At a glance

  • Drugs Udenafil (Primary)
  • Indications Benign prostatic hyperplasia; Erectile dysfunction; Portal hypertension; Pulmonary hypertension
  • Focus Adverse reactions
  • Sponsors Takeda
  • Most Recent Events

    • 29 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top